Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.980
+0.050 (1.27%)
At close: Mar 9, 2026, 4:00 PM EDT
3.980
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $37.34 million as of March 9, 2026.
Market Cap
37.34M
Enterprise Value
1.11M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $37.34M, a decrease of -78.13%. That is a compound annual growth rate of -81.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 36.87M | -8.60% |
| Dec 31, 2025 | 40.34M | -76.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 39.00M |
| Atossa Therapeutics | 37.80M |
| Jasper Therapeutics | 37.50M |
| Actinium Pharmaceuticals | 37.44M |
| Sensei Biotherapeutics | 36.47M |
| Celularity | 36.05M |
| PDS Biotechnology | 36.00M |
| INmune Bio | 35.89M |